Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals have?
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals has 446 citations in the OpenAlex counts ScholarIQ stores.
When was Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals published?
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals has 2009 year in the ScholarIQ index.
What is the open-access status of Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals?
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals has closed oa status in the ScholarIQ index.
What is the DOI of Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals?
The DOI for Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals is on the source record.
What is the PMID of Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals?
The PMID for Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals is on the source record.
What is the OpenAlex record for Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals?
The OpenAlex for Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals is on the source record.